Broader use of new MDR-TB drugs in treatment settings would bring immediate benefits to patients, Dr. KJ Seung of PIH and Dr. Cathy Hewison of MSF write in The Lancet Global Health this week.
The expansion will greatly improve Pleebo's capacity to meet emergency needs and provide care in areas ranging from hypertension and diabetes to maternal and child health.
Earth Day and COVID-19 are powerful reminders that social justice issues are interdependent and require global collaboration.
Lessons can be drawn from the treatment of TB, the world's deadliest infectious disease, to confronting COVID-19.
Dedicated care and new treatments have helped the Moleko family move from despair to hope in their multi-generational battles with TB.
Rapid tests are a key part of PIH's "unprecedented response" to COVID-19, amid challenges of testing in countries with minimal lab resources.
19 snapshots of how PIH brings justice to health care around the world
Join the infectious disease expert and PIH co-founder in Sierra Leone as he mentors clinicians through their most difficult cases.
Dr. Sheila Davis, who ran PIH's Ebola response in West Africa five years ago, reflects on the progress made helping to rebuild health systems in Liberia and Sierra Leone.
Thanks to investments from the Sierra Leonean government and PIH in multidrug-resistant tuberculosis treatment, 13-year-old Cylian Kargbo survived the disease. She's become an advocate for TB patients locally.